M
Michał Kąkol
Researcher at Gdańsk Medical University
Publications - 6
Citations - 452
Michał Kąkol is an academic researcher from Gdańsk Medical University. The author has contributed to research in topics: Cancer & GiST. The author has an hindex of 5, co-authored 6 publications receiving 388 citations.
Papers
More filters
Journal ArticleDOI
Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor
Piotr Rutkowski,Zbigniew Nowecki,Wanda Michej,Maria Debiec-Rychter,Agnieszka Woźniak,Janusz Limon,Janusz A. Siedlecki,Urszula Grzesiakowska,Michał Kąkol,Czesław Osuch,Marcin Polkowski,Stanisław Głuszek,Zbigniew Żurawski,Wlodzimierz Ruka +13 more
TL;DR: The risk criteria for assessing the natural course of primary GISTs were validated, but additional independent prognostic factors—primary tumor location and sex—were also identified.
Journal ArticleDOI
Preoperative nutritional support in cancer patients with no clinical signs of malnutrition—prospective randomized controlled trial
Pawel Kabata,Tomasz Jastrzębski,Michał Kąkol,Karolina Król,Maciej Bobowicz,Anna Kosowska,Janusz Jaśkiewicz +6 more
TL;DR: Preoperative nutritional support should be introduced for nonmalnourished patients as it helps to maintain proper nutritional status and reduce number and severity of postoperative complications compared with patients without such support.
Journal ArticleDOI
Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Piotr Rutkowski,Agnieszka Wozniak,Maria Debiec-Rychter,Michał Kąkol,Wirginiusz Dziewirski,Marcin Zdzienicki,Konrad Ptaszyński,Monika Jurkowska,Janusz Limon,Janusz A. Siedlecki +9 more
TL;DR: The reliability of the new revision of the American Joint Committee on Cancer (AJCC) staging system for gastrointestinal stromal tumors (GISTs) based on the National Comprehensive Cancer Network‐Armed Forces Institute of Pathology risk classification is assessed.
Journal ArticleDOI
Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs).
Piotr Rutkowski,Zbigniew Nowecki,Maria Debiec-Rychter,Urszula Grzesiakowska,Wanda Michej,Agnieszka Woźniak,Janusz A. Siedlecki,Janusz Limon,Anna Jerzak vel Dobosz,Michał Kąkol,Czesław Osuch,Wlodzimierz Ruka +11 more
TL;DR: Many advanced GIST patients benefit from IM therapy for a prolonged time, although resistance to therapy is observed, and four independent biological factors influencing the PFS during long-term IM therapy are identified.
Journal ArticleDOI
Antibiotic prophylaxis in open inguinal hernia repair: a literature review and summary of current knowledge.
Mateusz Zamkowski,Wojciech Makarewicz,Jerzy Ropel,Maciej Bobowicz,Michał Kąkol,Maciej Śmietański +5 more
TL;DR: This review documents clinical trials on inguinal hernia repairs with mesh and summarizes the current knowledge, and tries to solve certain problems: what constitutes a real risk factor, late-onset infection, and how the “surgical environment” impacts on the need to use antibiotic prophylaxis.